| Number (%) |
---|---|
Total deaths | 16 (100) |
Gender (Male) | 8 (50) |
Age (months); Median (range) | 11.5 (4–110) |
WHO* CD4 depletion | Â |
   not significant | 2 (13) |
   mild | 0 (0) |
   advanced | 1 (6) |
   severe | 13 (81) |
WHO clinical stage | Â |
   III | 1 (6) |
   IV | 15 (94) |
Disease manifestation | Â |
   Intra-thoracic TB | 8 (50) |
   Extra- and intra-thoracic TB | 5 (31) |
   Culture-confirmed M. tuberculosis | 7 (44) |
   MDR** TB | 2 (13) |
   TB & BCG# disease | 1 (6) |
   NTM## | 1 (6) |
Timing of death in relation to start of TB treatment | Â |
   <2 months | 6 (38) |
   ≥2 months | 10 (62) |
Timing of death in relation to HAART initiation | Â |
   <2 weeks | 5 (31) |
   2 weeks – 6 months | 9 (56) |
   >6 months | 2 (13) |